These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 30880941)

  • 21. Aerosol delivery via invasive ventilation: a narrative review.
    Lin HL; Fink JB; Ge H
    Ann Transl Med; 2021 Apr; 9(7):588. PubMed ID: 33987286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient perceptions of the re-usable Respimatt
    Dreher M; Price D; Gardev A; Peeters P; Arora S; van der Sar-van der Brugge S; Dekhuijzen R; Usmani OS
    Chron Respir Dis; 2021; 18():1479973120986228. PubMed ID: 33522304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical evaluation of the epithelial sodium channel inhibitor BI 1265162 for treatment of cystic fibrosis.
    Nickolaus P; Jung B; Sabater J; Constant S; Gupta A
    ERJ Open Res; 2020 Oct; 6(4):. PubMed ID: 33313305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Non-Interventional Study of Tiotropium/Olodaterol versus Any Triple Combination Therapy for Chronic Obstructive Pulmonary Disease: The EVELUT
    Buhl R; Dreher M; Korn S; Taube C; Stock C; Zehendner CM; Kondla A; Vogelmeier CF
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2601-2608. PubMed ID: 33122898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal Connection for Tiotropium SMI Delivery through Mechanical Ventilation: An In Vitro Study.
    Fang TP; Chen YJ; Yang TM; Wang SH; Hung MS; Chiu SH; Li HH; Fink JB; Lin HL
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32213833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporating the Environmental Impact into a Budget Impact Analysis: The Example of Adopting RESPIMAT
    Ortsäter G; Borgström F; Baldwin M; Miltenburger C
    Appl Health Econ Health Policy; 2020 Jun; 18(3):433-442. PubMed ID: 31808066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT
    Ortsäter G; Borgström F; Soulard S; Miltenburger C
    Adv Ther; 2019 Dec; 36(12):3435-3445. PubMed ID: 31625130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tiotropium/Olodaterol: A Review in COPD.
    Blair HA
    Drugs; 2019 Jun; 79(9):997-1008. PubMed ID: 31119643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease.
    Kässner F; Hodder R; Bateman ED
    Drugs; 2004; 64(15):1671-82. PubMed ID: 15257628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving usability and maintaining performance: human-factor and aerosol-performance studies evaluating the new reusable Respimat inhaler.
    Dhand R; Eicher J; Hänsel M; Jost I; Meisenheimer M; Wachtel H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():509-523. PubMed ID: 30880941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced Environmental Impact of the Reusable Respimat
    Hänsel M; Bambach T; Wachtel H
    Adv Ther; 2019 Sep; 36(9):2487-2492. PubMed ID: 31317391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland.
    Tschacher A; Cadus C; Schildge S; Diedrich JP; Chhajed PN; Leuppi-Taegtmeyer AB; Leuppi JD
    Curr Med Res Opin; 2021 Nov; 37(11):2019-2033. PubMed ID: 34433362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of switching tiotropium HandiHaler® to Respimat® Soft Mist™ Inhaler in patients with COPD: the difference of adverse events and usability between inhaler devices.
    Asakura Y; Nishimura N; Maezawa K; Terajima T; Kizu J; Chohnabayashi N
    J Aerosol Med Pulm Drug Deliv; 2013 Feb; 26(1):41-5. PubMed ID: 22691112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
    Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
    J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Respimat
    Iwanaga T; Tohda Y; Nakamura S; Suga Y
    Clin Drug Investig; 2019 Nov; 39(11):1021-1030. PubMed ID: 31377981
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.